Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
[Alternating hemiplegia with epilepsy].
N V Chebanenko1, V P Zykov1, I B Komarova1
1Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
A child with alternating hemiplegia and epilepsy had seizures diagnosed using video-EEG monitoring. Genetic testing identified an ATP1A3 gene mutation, leading to targeted therapy that successfully stopped both seizure types.
Area of Science:
- Neurology
- Genetics
- Epileptology
Background:
- Alternating hemiplegia of childhood (AHC) is a rare neurological disorder characterized by recurrent episodes of unilateral motor impairment.
- Epilepsy is a common neurological condition involving recurrent seizures, which can sometimes complicate the diagnosis of other disorders.
- The co-occurrence of AHC and epilepsy presents diagnostic challenges due to overlapping or distinct seizure manifestations.
Observation:
- A pediatric case presented with complex seizure activity, initially hindering a definitive diagnosis.
- Video-electroencephalography (EEG) monitoring was crucial in differentiating between epileptic and non-epileptic seizures occurring concurrently with different patterns.
- Simultaneous epileptic and non-epileptic seizures were identified, complicating the clinical picture.
Findings:
- Genetic analysis, including genome-wide sequencing, confirmed a mutation in the ATP1A3 gene, the known cause of AHC.
- The identified ATP1A3 gene mutation provided a definitive genetic diagnosis for the patient's condition.
- Timely initiation of targeted therapy based on the genetic diagnosis was achieved.
Implications:
- This case highlights the importance of advanced diagnostic tools like video-EEG and genetic sequencing in complex neurological cases.
- Targeted therapy directed at the underlying genetic defect (ATP1A3 mutation) proved effective in managing both epileptic and non-epileptic seizures.
- Successful treatment demonstrates the potential for precision medicine in managing rare genetic neurological disorders like AHC with co-existing epilepsy.
More Related Videos
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...